ECM
ANTH

Element Capital Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Element Capital Management’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-43,107
Closed -$70K – 132
2017
Q2 		$70K Buy
+43,107
New +$96.7K 0.01% 132

Other funds holding ANTH

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Element Capital Management's ANTH Position: Q3 2017 in Review

Element Capital Management sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q3 2017, closing a stake of 43,107 shares — an estimated $70K sold.

Element Capital Management first reported a position in ANTH in Q2 2017 and held it in 1 quarter. The position peaked at $70K in Q2 2017. 35 funds tracked by Wall St. Rank hold ANTH as of Q3 2017.

  • Element Capital Management reported no remaining Anthera Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
  • Element Capital Management sold 43,107 Anthera Pharmaceuticals, Inc. shares in Q3 2017, an estimated $70K.
  • Element Capital Management first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2017 and held it in 1 quarter.
  • Element Capital Management's Anthera Pharmaceuticals, Inc. position peaked at $70K in Q2 2017.
  • 35 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q3 2017.

Based on Element Capital Management's 13F filing for Q3 2017, filed 13 Nov 2017.